Published in J Exp Med on February 01, 1966
Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med (1966) 2.68
Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition. J Exp Med (1976) 2.01
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Enzymatic and immunologic alterations in mice infected with lactic dehydrogenase virus. Am J Pathol (1971) 1.37
Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement. J Exp Med (1974) 1.10
Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Immunology (1977) 1.04
Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infect Immun (1982) 0.98
Studies on the mechanism of action of Riley virus. IV. The reticuloendothelial system and impaired plasma enzyme clearance in infected mice. J Exp Med (1967) 0.94
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Divergence between immunosuppression and immunocompetence during virus-induced leukemogenesis. Proc Natl Acad Sci U S A (1971) 0.89
Immunoglobulin classes of Aleutian disease virus antibody. Infect Immun (1984) 0.86
Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus. Clin Exp Immunol (1978) 0.84
Antibody-producing cells: virus-induced alteration of response to antigen. Proc Natl Acad Sci U S A (1976) 0.82
Infection with LDH virus alters host response to tumours. Br J Cancer (1979) 0.82
Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus. J Am Assoc Lab Anim Sci (2013) 0.77
Lactic dehydrogenase virus infection enhances parasite egg production and inhibits eosinophil and mast cell responses in mice infected with the nematode Nippostrongylus brasiliensis. Immunology (1998) 0.75
Immune reactivity of Visna virus-inoculated mice. Infect Immun (1978) 0.75
Passive haemagglutination for estimation of early and late anti-human gamma-globulin antibodies. Immunology (1966) 0.75
The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera. J Exp Med (1951) 29.48
A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis (1959) 22.10
Antigen elimination from the blood as an early manifestation of the immune response. J Immunol (1951) 8.92
Antibody formation in vitro. J Exp Med (1961) 7.49
Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen. J Exp Med (1963) 6.74
Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology (1962) 6.24
ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL. ANTIBODY-INDUCED SUPPRESSION OF 19S AND 7S ANTIBODY RESPONSE. J Exp Med (1965) 4.89
The retention of S35-labelled bovine serum albumin in normal and immunized rabbit liver tissue. J Exp Med (1957) 4.71
PHAGOCYTOSIS OF THE ANTIGEN, A CRUCIAL STEP IN THE INDUCTION OF THE PRIMARY RESPONSE. Proc Natl Acad Sci U S A (1965) 3.05
Elimination of 131-I-labelled protein antigens from the circulation of the mouse. Immunology (1960) 2.77
LACTIC DEHYDROGENASE VIRUS. Bacteriol Rev (1965) 2.53
Human serum macroglobulins and dissociation units. I. Physicochemical properties. J Biol Chem (1958) 2.52
The use of plastics in the design of isolator systems. Ann N Y Acad Sci (1959) 2.35
TOLERANCE TO A PROTEIN ANTIGEN IN ADULT MICE AND THE EFFECT OF NONSPECIFIC FACTORS. J Immunol (1963) 2.31
STUDIES ON THE ADJUVANT ACTION OF BACTERIAL ENDOTOXINS ON ANTIBODY FORMATION. VI. ENHANCEMENT OF ANTIBODY FORMATION BY NUCLEIC ACIDS. J Immunol (1965) 2.18
INTRACELLULAR DISTRIBUTION AND DEGRADATION OF BACTERIOPHAGE IN MAMMALIAN TISSUES. J Immunol (1965) 1.90
ANTIBODY RESPONSE TO IMMUNIZATION BY DIFFERENT ROUTES. Science (1964) 1.89
STUDIES ON MOUSE ANTIBODIES. II. MERCAPTOETHANOL-SENSITIVE 7 S ANTIBODIES IN MOUSE ANTISERA TO PROTEIN ANTIGENS. J Immunol (1965) 1.83
FETAL RESPONSE TO ANTIGENIC STIMULUS. III. GAMMA-GLOBULIN PRODUCTION IN NORMAL AND STIMULATED FETAL LAMBS. J Immunol (1963) 1.63
INFLUENCE OF OLIGODEOXYRIBONUCLEOTIDES ON EARLY EVENTS IN ANTIBODY FORMATION. Proc Soc Exp Biol Med (1965) 1.59
Studies on the multiplication and the properties of the lactic dehydrogenase agent. J Exp Med (1963) 1.44
The restoration of hemolysin formation in x-rayed rabbits by nucleic acid derivatives and antagonists of nucleic acid synthesis. J Infect Dis (1961) 1.32
Sensitivity of passive haemagglutination for assay of 7S and 19S antibodies in primary rabbit anti-bovine serum albumin sera. Nature (1965) 1.28
Studies of a virus isolated from a wild house mouse, Mus musculus, and producing splenomegaly and lymph node enlargement in mice. Aust J Exp Biol Med Sci (1961) 1.24
ACTION OF RILEY'S PLASMA ENZYME-ELEVATING VIRUS IN MICE. Virology (1964) 1.20
RECOVERY OF AN INFECTIOUS RIBONUCLEIC ACID FROM THE LACTIC DEHYDROGENASE AGENT BY TREATMENT WITH ETHER. Virology (1964) 1.18
IDENTIFICATION OF WM1 AS LDH VIRUS, AND ITS RECOVERY FROM WILD MICE IN MARYLAND. Proc Soc Exp Biol Med (1965) 1.13
SPECIFICITY OF REACTION TO ANTIGENIC STIMULATION IN LYMPH NODES OF IMMATURE RABBITS. I. MORPHOLOGIC CHANGES AND GAMMA-GLOBULIN PRODUCTION FOLLOWING STIMULATION WITH DIPHTHERIA TOXOID AND SILICA. J Immunol (1963) 1.06
ULTRASTRUCTURE OF THE LACTIC DEHYDROGENASE VIRUS (LDV) AND CELL-VIRUS RELATIONSHIPS. Virology (1965) 1.00
EXPERIMENTAL OBSERVATIONS ON THE PARTICIPATION OF MACROPHAGES IN THE MECHANISM OF ANTIBODY PRODUCTION. Experientia (1963) 0.80
Maintenance of globulin levels in x-irradiated rabbits after immunization. Science (1962) 0.79
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol (1981) 10.92
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet (1974) 8.13
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem (1968) 7.13
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46
Metabolism of immunoglobulins. Prog Allergy (1969) 5.74
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
Clustered arrangement of immunoglobulin lambda constant region genes in man. Nature (1981) 4.87
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med (1968) 4.19
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A (1985) 3.74
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A (1981) 3.73
Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature (1981) 3.64
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62
Metabolic properties of IgG subclasses in man. J Clin Invest (1970) 3.48
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med (1968) 3.33
The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science (1986) 3.32
Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27
Protein-losing enteropathy. Gastroenterology (1966) 3.21
The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med (1967) 3.06
Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 2.96
Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med (1983) 2.96
Thymus dependence of viral antigens. Nature (1975) 2.95
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science (1972) 2.91
Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest (1966) 2.91
Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol (1968) 2.90
The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest (1972) 2.88
Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med (1967) 2.87
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A (2000) 2.80
The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.79
Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice. J Virol (1987) 2.78
Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci U S A (1983) 2.76
Variable amplification of immunoglobulin lambda light-chain genes in human populations. Nature (1983) 2.75
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A (1983) 2.73
Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science (1974) 2.71
Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med (1966) 2.68
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J Immunol (1983) 2.65
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol (1989) 2.63
Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms. Ann N Y Acad Sci (1966) 2.61
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol (1969) 2.54
A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.51
Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47
The mechanism of appearance of immunoglobulin A in nasal secretions in man. J Clin Invest (1967) 2.45
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med (1973) 2.42
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science (1985) 2.34
The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest (1976) 2.32
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity (1996) 2.23
A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 2.23
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol (1974) 2.23
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A (1987) 2.22
Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J Immunol Methods (1980) 2.21
Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen. J Immunol (1984) 2.20
Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci U S A (2003) 2.20
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J Immunol (1973) 2.18
Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol (1969) 2.18
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med (1971) 2.15
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci U S A (1999) 2.14
Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol (1994) 2.13
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (1989) 2.13
Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A (1986) 2.12
Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells. Infect Immun (1980) 2.12
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med (1984) 2.10
Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) (1977) 2.07
Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med (1980) 2.07
T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc Natl Acad Sci U S A (1991) 2.03
Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood (1990) 2.02
Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med (1989) 1.99
Suppressor cells in the regulation of the immune response. Prog Clin Immunol (1977) 1.99
Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology (1978) 1.99
Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells. J Immunol (1984) 1.99